The basis for Amarin Corp. PLC's argument that some omega-3 imports are unfair competition for a drug it markets already has been rejected, says the federal government in urging the US Supreme Court to deny the firm's petition to consider its request for a fair trade investigation.
Amarin does not assert in its petition to the Supreme Court that it makes any fair trade claim "that could...








